Fragile X CGG repeat structures among African-Americans: Identification of a novel factor responsible for repeat instability

Human Molecular Genetics

Volumn 9, Issue 12, 2000, Pages 1759-1769

  Crawford, Dana C ^a   Zhang, Fuping ^a   Wilson, Beth ^a   Warren, Stephen T ^a,b   Sherman, Stephanie L ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CAUCASIAN; CHROMOSOME SIZE; FRAGILE X SYNDROME; GENETIC STABILITY; HAPLOTYPE; HUMAN; MALE; NEGRO; PREVALENCE; PRIORITY JOURNAL; TRINUCLEOTIDE REPEAT;

EID: 0033854462     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/9.12.1759     Document Type: Article

References (62)

1. Genetic instabilities and hereditary neurological diseases
2. Trinucleotide instability: A repeating theme in human inherited disorders
3. Trinucleotide repeat expansion and human disease
4. Simple tandem DNA repeats and human genetic disease
5. Prevalence of fragile X syndrome
6. Population screening at the FRAXA and FRAXE loci: Molecular analyses of boys with learning difficulties and their mothers
7. Screening and diagnosis for the fragile X syndrome among the mentally retarded: An epidemiological and psychological survey Collaborative. Fragile X Study Group
8. Fragile X syndrome is less common than previously estimated
9. Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse special education needs population
10. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome
11. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n
12. Fragile-X syndrome: Unique genetics of the heritable unstable element
13. Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the sherman paradox
14. Physical mapping across the fragile X: Hypermethylation and clinical expression of the fragile X syndrome
15. DNA methylation represses FMR-1 transcription in fragile X syndrome
16. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells
17. Absence of expression of the FMR-1 gene in fragile X syndrome
18. FMR1 protein: Conserved RNP family domains and selective RNA binding
19. 21 from the fragile X gene remain stable in transgenic mice
20. Long uninterrupted CGG repeats within the first exon of the human FMR1 gene are not intrinsically unstable in transgenic mice
21. 81 is stable in mice
22. Inheritance of the fragile X syndrome: Size of the fragile X premutation is a major determinant of the transition to full mutation
23. Examination of factors that influence the expansion of the fragile X mutation in a sample of conceptuses from known carrier females
24. Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population
25. Familial transmission of the FMR1 CGG repeat
26. Examination of factors associated with instability of the FMR1 CGG repeat
27. Sequence analysis of the fragile X trinucleotide repeat: Implications for the origin of the fragile X mutation
28. Precursor arrays for triplet repeat expansion at the fragile X locus
29. Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles
30. Fragile X gene instability: Anchoring AGGs and linked microsatellites
31. Length of uninterrupted CGG repeats determines instability in the FMR1 gene
32. Modeling the natural history of the fragile X gene
33. Haplotype and interspersion analysis of the FMR1 CGG repeat identifies two different mutational pathways for the origin of the fragile X syndrome
34. Reexamination of factors associated with expansion of CGG repeats using a single nucleotide polymorphism in FMR1
35. Predisposition to the fragile X syndrome in Jews of Tunisian descent is due to the absence of AGG interruptions on a rare Mediterranean haplotype
36. Prevalence of fragile-X syndrome and FRAXE among children with intellectual disability in a Caribbean island, Guadeloupe, French West Indies
37. FRAXA and FRAXE prevalence in patients with nonspecific mental retardation in the Hellenic population
38. Molecular screening of Fragile X (FRAXA) and FRAXE mental retardation syndromes in the Hellenic population of Greece and Cyprus
39. Pilot fragile X screening in normal population of Taiwan
40. Population survey of the human FMR1 CGG repeat substructure suggests biased polarity for the loss of AGG interruptions
41. 6AGG insertion within the CGG repeat of the FMR1 gene in Asians
42. Analysis of FMR1 (CGG)n alleles and FRAXA microsatellite haplotypes in the population of Greenland: Implications for the population of the new world from Asia
43. Genetic variation and evolutionary stability of the FMR1 CGG repeat in six closed human populations
44. FMR1 in global populations
45. Sequence analysis of long FMR1 arrays in the Japanese population: Insights into the generation of long (CGG)n tracts
46. Distribution of FMR-1 and associated microsatellite alleles in a normal Chinese population
47. Haplotype analysis at the FRAXA locus in the Japanese population
48. Extended gene diversity at the FMR1 locus and neighbouring CA repeats in a sub-Saharan population
49. No founder effect detected in Jewish Ashkenazi patients with fragile-X syndrome
50. FRAXAC1 and DXS548 polymorphisms in the Chinese population
51. Survey of the fragile X syndrome CGG repeat and short-tandem-repeat and single-nucleotide-polymorphism haplotypes in an African American population
52. Survey of the fragile X syndrome and the fragile X E syndrome in a special education needs population
53. A complex mutable polymorphism located within the fragile X gene
54. Recombination of DXS548 (RS46) with the FRAXA locus [letter]
55. The role of size, sequence and haplotype in the stability of FRAXA and FRAXE alleles during transmission
56. Stabilizing effects of interruptions on trinucleotide repeat expansions in Saccharomyces cerevisiae
57. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test
58. Automated detection of trinucleotide repeats in fragile X syndrome
59. Expand long PCR for fragile X mutation detection
60. Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines
61. The fragile X site in somatic cell hybrids: An approach for molecular cloning of fragile sites
62. Estimation of average heterozygosity and genetic distance from a small number of individuals